0.41%| Prev Close: | 1.56 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 3.50 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 1.23 - 2.73 |
| Volume: | 0 |
| Avg Vol (3m): | 79,000 |
| Market Cap: | 70.23M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: Cleveland Biolabs secures $10 mln loan agreement with Hercules Technology Growth Capital (HTGC)Briefing.com(Tue, Oct 1)
- Cleveland BioLabs Secures $10 Million Loan Agreement With Hercules Technology Growth CapitalGlobeNewswire(Tue, Oct 1)
- Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 European Cancer CongressGlobeNewswire(Thu, Sep 19)
- Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 ASCP Annual MeetingGlobeNewswire(Thu, Sep 12)
- CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FinancialEDGAR Online(Thu, Sep 5)
- CLEVELAND BIOLABS INC FinancialsEDGAR Online Financials(Tue, Aug 20)
- Here’s How Russia Is Helping Grow the Biotech Sectorat Wall St. Cheat Sheet(Sat, Aug 17)
- Cleveland BioLabs' CEO Discusses Q2 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Aug 13)
- Q2 2013 CLEVELAND BIOLABS INC Earnings Release - Before Market OpenCCBN(Tue, Aug 13)
- Cleveland BioLabs Reports Second Quarter 2013 Financial Results and Development ProgressGlobeNewswire(Tue, Aug 13)
- Cleveland Biolabs Earnings Preview: Get Ahead of the Analystsat Wall St. Cheat Sheet(Sun, Aug 11)
- CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Aug 9)
- 4 Healthcare Stock Stories For a Midweek Investment Checkupat Wall St. Cheat Sheet(Wed, Aug 7)
- Cleveland BioLabs and Incuron Announce Start of US Trial With CBL0137GlobeNewswire(Wed, Aug 7)
- Cleveland BioLabs to Report Second Quarter 2013 Financial Results and Provide Operational Update on August 13GlobeNewswire(Thu, Aug 1)
Press Releases
- Cleveland BioLabs Secures $10 Million Loan Agreement With Hercules Technology Growth CapitalGlobeNewswire(Tue, Oct 1)
- Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 European Cancer CongressGlobeNewswire(Thu, Sep 19)
Reports
- CBLI: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Oct 1)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(Oct 1)
- Cleveland BioLabsS&P Capital IQ Quantitative Report(Sep 28)